Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wulf H Utian

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Health and Quality of Life Outcomes|August 9, 2005
Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive reviewWulf H Utian
Maturitas|March 21, 2007
Quality of life (QOL) in menopauseWulf H Utian
Menopause (New York, N.Y.)|November 3, 2007
NIH and WHI: time for a mea culpa and steps beyondWulf H Utian
Drugs|October 9, 2012
Pharmacy compounding primer for physicians: prescriber bewareSarah Sellers, Wulf H Utian
Menopause (New York, N.Y.)|October 26, 2018
NAMS-gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapyWulf H Utian, Isaac Schiff
Menopause (New York, N.Y.)|June 27, 2013
Impact of hormone therapy on quality of life after menopauseWulf H Utian, Nancy Fugate Woods
Journal of Women'S Health (2002)|February 19, 2015
S-equol: a potential nonhormonal agent for menopause-related symptom reliefWulf H Utian, Michelle Jones, Kenneth D R Setchell
Menopause (New York, N.Y.)|November 10, 2005
Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptomsWulf H Utian, Leon Speroff, Herman Ellman, et al.
Menopause (New York, N.Y.)|May 29, 2004
Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal womenWulf H Utian, Margery L S Gass, James H Pickar
Obstetrics and Gynecology|October 2, 2007
Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trialGloria A Bachmann, Matthias Schaefers, Alkaz Uddin, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Health and Quality of Life Outcomes|August 9, 2005
Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive reviewWulf H Utian
Maturitas|March 21, 2007
Quality of life (QOL) in menopauseWulf H Utian
Menopause (New York, N.Y.)|November 3, 2007
NIH and WHI: time for a mea culpa and steps beyondWulf H Utian
Drugs|October 9, 2012
Pharmacy compounding primer for physicians: prescriber bewareSarah Sellers, Wulf H Utian
Menopause (New York, N.Y.)|October 26, 2018
NAMS-gallup survey on women's knowledge, information sources, and attitudes to menopause and hormone replacement therapyWulf H Utian, Isaac Schiff
Menopause (New York, N.Y.)|June 27, 2013
Impact of hormone therapy on quality of life after menopauseWulf H Utian, Nancy Fugate Woods
Journal of Women'S Health (2002)|February 19, 2015
S-equol: a potential nonhormonal agent for menopause-related symptom reliefWulf H Utian, Michelle Jones, Kenneth D R Setchell
Menopause (New York, N.Y.)|November 10, 2005
Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptomsWulf H Utian, Leon Speroff, Herman Ellman, et al.
Menopause (New York, N.Y.)|May 29, 2004
Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal womenWulf H Utian, Margery L S Gass, James H Pickar
Obstetrics and Gynecology|October 2, 2007
Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trialGloria A Bachmann, Matthias Schaefers, Alkaz Uddin, et al.
Pageof 4